Novartis Bids On "Superstatin": Seeking U.S. Rights To Pitavastatin

Novartis is in negotiations for the U.S. rights to pitavastatin with Sankyo and Nissan Chemicals, CEO Daniel Vasella, MD, told the New York Society of Securities Analysts June 5.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet